≥98%HPLC Purity
COAIncluded
USAShipped
Fragment/CJC/Ipamorelin Blend Peptide
Triple-action growth hormone axis research blend: HGH Fragment 176-191 (lipolysis) + CJC-1295 (GHRH analog) + Ipamorelin (GHS). Synergistic GH research compound.
Coming Soon
This compound is currently in our development pipeline. Enter your email to be notified when it becomes available for research purchase.
Quick Facts
| SKU | FCIB-001 |
|---|---|
| Purity | ≥98% |
| Physical Form | Lyophilized Powder |
| Storage | Store at -20°C |
What is Fragment/CJC/Ipamorelin Blend?
Triple-action GH axis research blend combining HGH Fragment 176-191 (direct lipolysis via beta-3 adrenergic pathway), CJC-1295 (sustained GHRH receptor activation for GH elevation), and Ipamorelin (selective ghrelin receptor-mediated GH pulse). The three compounds target different GH-related pathways for comprehensive growth hormone axis research.
Frequently Asked Questions
Why combine these three compounds?
Each targets a different GH pathway: Fragment 176-191 directly stimulates fat cell lipolysis, CJC-1295 provides sustained GHRH signaling, and Ipamorelin triggers clean GH pulses via ghrelin receptor. Together they provide multi-pathway GH axis stimulation.
For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.
